.

BioPharmaceutical Business Intelligence

  • Analyze global market entry opportunities
  • Uncover prior art in expired and abandoned patents
  • Drug patents in 130+ countries

Upgrade to enjoy subscriber-only features like email alerts and data export. See the Plans and Pricing

Serving leading biopharmaceutical companies globally:

Federal Trade Commission
QuintilesIMS
Farmers Insurance
Merck
Harvard Business School
Colorcon
Mallinckrodt
Boehringer Ingelheim
Citi
McKesson

Generated: December 13, 2017

DrugPatentWatch Database Preview

Combe Company Profile

« Back to Dashboard

What is the competitive landscape for COMBE, and what generic and branded alternatives to COMBE drugs are available?

COMBE has four approved drugs.



Summary for Combe

US Patents:0
Tradenames:3
Ingredients:4
NDAs:4
Applicant Tradename Generic Name Dosage NDA Approval Date TE Type RLD RS Patent No. Patent Expiration Patent Submitted Product Substance Delist Req. Exclusivity Expiration
CombeBACITRACINbacitracinOINTMENT;TOPICAL062799-001May 14, 1987DISCNNoNo► Subscribe► Subscribe► Subscribe► Subscribe
CombeVAGISTAT-1tioconazoleOINTMENT;VAGINAL020676-001Feb 11, 1997OTCYesYes► Subscribe► Subscribe► Subscribe► Subscribe
CombeLANABIOTICbacitracin zinc; lidocaine; neomycin sulfate; polymyxin b sulfateOINTMENT;TOPICAL062499-001Jun 3, 1985DISCNNoNo► Subscribe► Subscribe► Subscribe► Subscribe
CombeLANABIOTICbacitracin; polymyxin b sulfateDISC;TOPICAL050598-001Sep 22, 1986DISCNNoNo► Subscribe► Subscribe► Subscribe► Subscribe
This preview shows a limited data set
Subscribe for full access, or try a Trial

Export unavailable in trial.
Subscribe for complete access.

Similar Applicant Names

Individual applicants are sometimes listed under multiple names.
Here is a list of applicants with similar names.

« Back to Dashboard

For more information try a trial or see the plans and pricing

Serving leading biopharmaceutical companies globally:

McKesson
Healthtrust
Covington
Moodys
Argus Health
Fuji
QuintilesIMS
Boehringer Ingelheim
Federal Trade Commission
UBS

Drugs may be covered by multiple patents or regulatory protections. All trademarks and applicant names are the property of their respective owners or licensors. Although great care is taken in the proper and correct provision of this service, thinkBiotech LLC does not accept any responsibility for possible consequences of errors or omissions in the provided data. The data presented herein is for information purposes only. There is no warranty that the data contained herein is error free. thinkBiotech performs no independent verifification of facts as provided by public sources nor are attempts made to provide legal or investing advice. Any reliance on data provided herein is done solely at the discretion of the user. Users of this service are advised to seek professional advice and independent confirmation before considering acting on any of the provided information. thinkBiotech LLC reserves the right to amend, extend or withdraw any part or all of the offered service without notice.

Copyright 2002-2017 thinkBiotech LLC
ISSN: 2162-2639

Secure SSL Encrypted
Privacy and Cookies
Terms & Conditions

Follow DrugPatentWatch:

botpot